SECTOR
Pharmaceuticals
COUNTRY
India
Scroll Up Top
Print icon
Print
Invested on
Apr 2024
Transaction Type
Joint Control

Maiva is India’s #2 largest pure-play injectables CDMO. It provides provides the full lifecycle of product development and manufacturing services to pharma marketers in regulated markets. It operates a USFDA approved plant with strong R&D capabilities and successful regulatory track record. It has a vast basket of approved products across therapy segments and covered in US shortage list 

 

As of July 25, 2025. The above is provided for informational and educational purposes only. There is no guarantee that the investment mentioned resulted in positive performance (for realized holdings), or will perform well in the future (for current holdings). The trademarks and service marks above are the property of their respective owners. The information on this website has not been authorized, sponsored, or otherwise approved by such owners. By clicking on any links shown here, you agree that you are navigating to a third party site. We are providing these hyperlinks to you only as a convenience and the inclusion of any hyperlink is not and does not imply any endorsement, approval, investigation, verification or monitoring by us of any information contained in any hyperlinked site. In no event shall we be responsible for the information contained on the site or your use of such site.